Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE

AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE

Standard Dose
EQ 40MG MEDOXOMIL;12.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE is listed in Drugs@FDA under application 217490 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE Form and strength TABLET;ORAL - EQ 40MG MEDOXOMIL;12.5MG Sponsor ALKEM LABS LTD Submission history Latest submission status date: 2025-01-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE is listed in Drugs@FDA under application 217490 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE Form and strength TABLET;ORAL - EQ 40MG MEDOXOMIL;12.5MG Sponsor ALKEM LABS LTD Submission history Latest submission status date: 2025-01-21 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE (AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE) | Drug Monograph | MedicHelpline